Ascletis Pharma (ASCLF) Projected to Post Quarterly Earnings on Tuesday

Ascletis Pharma (OTCMKTS:ASCLF) will likely be releasing its results before the market opens on Tuesday, March 31st. Analysts expect Ascletis Pharma to post earnings of ($0.04) per share for the quarter.

Ascletis Pharma Price Performance

Shares of Ascletis Pharma stock opened at $1.81 on Tuesday. The business has a 50-day moving average price of $1.91 and a 200 day moving average price of $1.65. Ascletis Pharma has a fifty-two week low of $0.62 and a fifty-two week high of $2.29.

Ascletis Pharma Company Profile

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).